Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wirth

Showing results (591-600 of 675) with videos related to

Pageof 68
Sort By:
Cytogenetics and Cell Genetics|November 4, 2000
Molecular cloning of Xp11 breakpoints in two unrelated mentally retarded females with X;autosome translocationsH G Nothwang, A Schröer, S van der Maarel, et al.
Chinese Medical Journal|June 16, 2021
A novel nomogram provides improved accuracy for predicting biochemical recurrence after radical prostatectomyHai-Zhui Xia, Hai Bi, Ye Yan, et al.
Thyroid : Official Journal of the American Thyroid Association|November 8, 2007
A phase II study of gefitinib in patients with advanced thyroid cancerNathan A Pennell, Gilbert H Daniels, Robert I Haddad, et al.
Thyroid : Official Journal of the American Thyroid Association|January 31, 2018
Circulating BRAF<sup>V600E</sup> Levels Correlate with Treatment in Patients with Thyroid CarcinomaCarrie C Lubitz, Tiannan Zhan, Viswanath Gunda, et al.
BMC Cancer|May 18, 2013
The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumorsLee S Rosen, Lara Lipton, Timothy J Price, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapyHale B Caglar, Roy B Tishler, Megan Othus, et al.
Cancers|August 12, 2022
The Prediction of Cardiac Events Using Contemporary Risk Prediction Models after Radiation Therapy for Head and Neck CancerRaza M Alvi, Thiago Quinaglia, Aferdita Spahillari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2009
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neckL J Wirth, A M Allen, M R Posner, et al.
Journal of the American Heart Association|September 1, 2017
Human Papillomavirus Status and the Risk of Cerebrovascular Events Following Radiation Therapy for Head and Neck CancerDaniel Addison, Sara B Seidelmann, Sumbal A Janjua, et al.
Physics in Medicine and Biology|March 6, 2020
Tracking tumor radiotherapy response in vivo with Cherenkov-excited luminescence ink imagingJennifer A Soter, Ethan P M LaRochelle, Brook K Byrd, et al.
Pageof 68

Showing results (591-600 of 675) with videos related to

Sort By:
Pageof 68
Cytogenetics and Cell Genetics|November 4, 2000
Molecular cloning of Xp11 breakpoints in two unrelated mentally retarded females with X;autosome translocationsH G Nothwang, A Schröer, S van der Maarel, et al.
Chinese Medical Journal|June 16, 2021
A novel nomogram provides improved accuracy for predicting biochemical recurrence after radical prostatectomyHai-Zhui Xia, Hai Bi, Ye Yan, et al.
Thyroid : Official Journal of the American Thyroid Association|November 8, 2007
A phase II study of gefitinib in patients with advanced thyroid cancerNathan A Pennell, Gilbert H Daniels, Robert I Haddad, et al.
Thyroid : Official Journal of the American Thyroid Association|January 31, 2018
Circulating BRAF<sup>V600E</sup> Levels Correlate with Treatment in Patients with Thyroid CarcinomaCarrie C Lubitz, Tiannan Zhan, Viswanath Gunda, et al.
BMC Cancer|May 18, 2013
The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumorsLee S Rosen, Lara Lipton, Timothy J Price, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapyHale B Caglar, Roy B Tishler, Megan Othus, et al.
Cancers|August 12, 2022
The Prediction of Cardiac Events Using Contemporary Risk Prediction Models after Radiation Therapy for Head and Neck CancerRaza M Alvi, Thiago Quinaglia, Aferdita Spahillari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2009
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neckL J Wirth, A M Allen, M R Posner, et al.
Journal of the American Heart Association|September 1, 2017
Human Papillomavirus Status and the Risk of Cerebrovascular Events Following Radiation Therapy for Head and Neck CancerDaniel Addison, Sara B Seidelmann, Sumbal A Janjua, et al.
Physics in Medicine and Biology|March 6, 2020
Tracking tumor radiotherapy response in vivo with Cherenkov-excited luminescence ink imagingJennifer A Soter, Ethan P M LaRochelle, Brook K Byrd, et al.
Pageof 68